Simon Tilley, head of pharmaceuticals, SAS UK and Ireland talks about how organisations can finalise a strategy for compliance with Identification of Medicinal Products (IDMP) standards and the opportunities that it can provide for driving more efficient collaboration among drug manufacturers, researchers and medical professionals
Simon Tilley, head of pharmaceuticals, SAS UK and Ireland